IndraLab
Statements
reach
"Despite significant advancements in the identification of potential molecular targets and signaling pathways within the realm of cardiac hypertrophy 34-37, the existing clinical pharmacological strategies for managing this condition remain unsatisfactory.To the best of our knowledge, this is the first study to demonstrate that OTUD1 promotes pathological cardiac hypertrophy by upregulating ASK1 phosphorylation."